Autoimmune Hemolytic Anemia in the Pediatric Setting

Area of Science:

• Pediatric Hematology
• Immunology
• Rare Diseases

Background:

• Autoimmune hemolytic anemia (AIHA) is a rare pediatric condition with varied severity.
• Warm AIHA involves IgG antibodies binding red blood cells (RBCs) at 37°C, leading to phagocytosis.
• Cold AIHA (CAS, PCH) involves cold-reactive antibodies causing hemolysis via complement activation in cold temperatures.

Purpose of the Study:

• To review the diagnosis and management of AIHA in children.
• To emphasize the importance of considering AIHA despite negative diagnostic tests.
• To highlight the need for screening underlying immune disorders in pediatric warm AIHA.

Main Methods:

• Review of current literature on pediatric AIHA.
• Discussion of diagnostic challenges, including DAT-negative cases.
• Outline of treatment strategies and the importance of identifying secondary causes.

Main Results:

• Direct antiglobulin test (DAT) is standard but can be negative in up to 11% of warm AIHA.
• Prompt supportive care, steroids for warm AIHA, and transfusions are crucial.
• Identifying underlying immune dysregulation is vital for prognosis and management of warm AIHA.

Conclusions:

• Pediatric AIHA requires prompt diagnosis and management, considering DAT-negative possibilities.
• Treatment involves supportive care, steroids, and transfusions as needed.
• Screening for associated immune disorders is essential for optimal long-term care in pediatric warm AIHA.